207 related articles for article (PubMed ID: 4612879)
1. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
[No Abstract] [Full Text] [Related]
2. [Vitality evaluation of malignant melanoma metastases following endolymphatic radionuclide therapy using the Falck-Hillarp method].
Paul E; Illig L; Möller W
Hautarzt; 1975 Jun; 26(6):317-20. PubMed ID: 1165195
[TBL] [Abstract][Full Text] [Related]
3. [Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].
Makoski HB; Scherer E; Magnus L; Verbeek W
Strahlentherapie; 1978 Mar; 154(3):169-73. PubMed ID: 635942
[TBL] [Abstract][Full Text] [Related]
4. Current status of endolymphatic therapy with radionuclides.
Peters PE; Weissleder H
Lymphology; 1974 Mar; 7(1):49-52. PubMed ID: 4851228
[No Abstract] [Full Text] [Related]
5. [The role of radiation therapy in the primary treatment of malignant melanoma].
Scherer E
Haematol Blood Transfus; 1978; 21():277-83. PubMed ID: 83952
[No Abstract] [Full Text] [Related]
6. [Radiotherapy of malignant melanoma].
Lissner J; von Lieven H
Chirurg; 1974 Aug; 45(8):362-5. PubMed ID: 4138547
[No Abstract] [Full Text] [Related]
7. [Therapy of endolymphatic metastastases in malignant melanoma using radioisotopes].
Weissleder H; Pfannenstiel P
Arch Dermatol Forsch; 1972; 244():245-50. PubMed ID: 4648699
[No Abstract] [Full Text] [Related]
8. [Follow-up studies on malignant melanomas after endolymphatic radionuclide therapy].
Gehring D; Baumeister L
Med Welt; 1974 Jun; 25(23):1045-7. PubMed ID: 4409591
[No Abstract] [Full Text] [Related]
9. [Evaluation of endo-lymphatic therapy of the VX2 tumour in the rabbit. Investigations using the beta-ray source P 32-tri-N-octyl-phosphate and the gamma source I 125-trioleine (author's transl)].
Magnus L
Fortschr Geb Rontgenstr Nuklearmed; 1973 Oct; 119(4):418-28. PubMed ID: 4359999
[No Abstract] [Full Text] [Related]
10. [Endolymphatic radiotherapy in malignant melanoma of the lower extremities].
Kalkoff P; Baumeister L; Gehring D
Arch Dermatol Forsch; 1972; 244():250-4. PubMed ID: 4648700
[No Abstract] [Full Text] [Related]
11. [Radiation-dosimetry studies after endolymphatic radionuclide therapy].
Pfannenstiel P
Med Welt; 1974 Jun; 25(23):1038-42. PubMed ID: 4369658
[No Abstract] [Full Text] [Related]
12. [Tabular and case demonstrations of 100 malignant melanomas treated by endolymphatic therapy].
Makoski HB; Scherer E
Med Welt; 1974 Jun; 25(23):1042-4. PubMed ID: 4605981
[No Abstract] [Full Text] [Related]
13. [Dose distribution in healthy lymph nodes and in lymph nodes affected by metastases after endolymphatic therapy with radionuclides].
Magnus L
Strahlentherapie; 1973 May; 145(5):571-81. PubMed ID: 4761818
[No Abstract] [Full Text] [Related]
14. [Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].
Müller RP; Schnepper E; Peters PE; Fladerer W
Strahlentherapie; 1980 Aug; 156(8):538-41. PubMed ID: 7414647
[TBL] [Abstract][Full Text] [Related]
15. [Results of lymphographic course controls following endolymphatic radionuclide therapy].
Wolf G
Med Welt; 1974 Jun; 25(23):1050-4. PubMed ID: 4410764
[No Abstract] [Full Text] [Related]
16. [Radiobiology in clinical trials for fast neutron therapy, with special reference to the treatment of malignant melanoma].
Tsunemoto H; Morita S; Ishikawa T; Mori S
Gan No Rinsho; 1983 Oct; 29(13):1554-60. PubMed ID: 6422097
[TBL] [Abstract][Full Text] [Related]
17. [Malignant melanoma of the skin].
Stein G
Z Haut Geschlechtskr; 1971 Jul; 46(13):409-14. PubMed ID: 5110514
[No Abstract] [Full Text] [Related]
18. Results of treating malignant melanoma intralymphatically with radioactive isotopes.
Ariel IM
Surg Gynecol Obstet; 1974 Nov; 139(5):726-30. PubMed ID: 4372734
[No Abstract] [Full Text] [Related]
19. [Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].
Müller RP; Peters PE
Strahlentherapie; 1985 Apr; 161(4):239-43. PubMed ID: 2986321
[TBL] [Abstract][Full Text] [Related]
20. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
Richter G; Heidenbluth I; Heidelbach U
Dermatol Monatsschr; 1982 Dec; 168(12):797-806. PubMed ID: 7169101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
